OKYO Pharma Director John P. Brancaccio Acquires 5,000 Shares

What Happened

• John P. Brancaccio, a director of OKYO Pharma Ltd (OKYO), purchased 5,000 shares in an open-market/ private purchase on July 21, 2026 at $1.48 per share, for a total of $7,385. This filing is an amendment (Form 4/A) that corrects only the transaction code for that purchase; no other transaction details were changed.

Key Details

• Transaction date: 2026-07-21; Price: $1.48 per share; Shares acquired: 5,000; Total value: $7,385.
• Transaction code: P (Purchase) — amended to correct the code in the original Form 4.
• Filing timeline: Original Form 4 was filed July 23, 2026 (timely). This Form 4/A was filed August 7, 2026 solely to correct the code.
• Shares owned after transaction: Not specified in the provided excerpt of the filing.
• No 10b5-1 plan, gift, option exercise, or tax-withholding notes were indicated in the supplied details.

Context

• The purchase is a straightforward insider buy by a company director. The dollar amount is modest ($7.4k), so while it shows insider buying, it is not a large stake. The amendment does not change the transaction amount or timing — it only corrects the transaction code reported to the SEC.